UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): January 11, 2010
Inverness Medical Innovations, Inc.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Delaware
|
|
001-16789
|
|
04-3565120 |
|
|
|
|
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission file number)
|
|
(IRS Employer
Identification No.) |
51 Sawyer Road, Suite 200, Waltham, Massachusetts 02453
(Address of principal executive offices)
Registrant’s telephone number, including area code: (781) 647-3900
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.142-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD disclosure.
On January 11, 2010, Inverness Medical Innovations, Inc. (the “Company”) and Dr. Young Shik Cho
jointly issued a press release in South Korea entitled “Dr. Young Shik Cho and IMI jointly
announces a plan to acquire a majority equity interest in Standard Diagnostics (SD),” a copy of
which is furnished with this Current Report on Form 8-K as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| |
|
|
| Exhibit No. |
|
Description |
|
|
|
99.1*
|
|
Press Release dated January 11, 2010, entitled “Dr. Young Shik
Cho and IMI jointly announces a plan to acquire a majority
equity interest in Standard Diagnostics (SD)” |